((7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinolin-1(2H)-yl)methoxy)methyl Dodecanoate
- CAS
- 1870867-21-2
- Formula
- C37H53Cl2N3O5
- MW
- 690.7 g/mol
VQ-043049
Impurity reference standards
Aripiprazole impurities & reference standards
Characterised Aripiprazole impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
67reference materials
1nitrosamine impurities
1isotope-labelled
COAHPLC · NMR · MS on request
Parent API: Aripiprazole
129722-12-9 · C23H27Cl2N3O2
1-(4-Bromobutyl)-4-(2,3-dichlorophenyl)piperazine
- CAS
- 874661-64-0
- Formula
- C14H19BrCl2N2
- MW
- 366.1 g/mol
VQ-035790
1-(But-3-en-1-yl)-4-(2,3-dichlorophenyl)piperazine
- CAS
- 1424857-93-1
- Formula
- C14H18Cl2N2
- MW
- 285.2 g/mol
VQ-020823
![1,4-Bis[3,4-dihydro-2(1H)-quinolinon-7-oxy]butane chemical structure](/media/structures/HYDKRRWQLHXDEN-UHFFFAOYSA-N.svg)
1,4-Bis[3,4-dihydro-2(1H)-quinolinon-7-oxy]butane
- CAS
- 882880-12-8
- Formula
- C22H24N2O4
- MW
- 380.4 g/mol
VQ-020671
3,4-Dihydro-7-(4-hydroxybutoxy)-2(1H)-quinolinone
- CAS
- 889443-20-3
- Formula
- C13H17NO3
- MW
- 235.28 g/mol
VQ-020672
5-(4-Bromobutoxy)-3,4-dihydroquinolin-2(1H)-one
- CAS
- 63309-35-3
- Formula
- C13H16BrNO2
- MW
- 298.18 g/mol
VQ-043978
7-(4-Chlorobutoxy)-3,4-dihydro-2(1H)-quinolinone
- CAS
- 120004-79-7
- Formula
- C13H16ClNO2
- MW
- 253.72 g/mol
VQ-020819
7-(But-3-en-1-yloxy)-3,4-dihydroquinolin-2(1H)-one
- CAS
- 1359829-23-4
- Formula
- C13H15NO2
- MW
- 217.26 g/mol
VQ-020822
![8-(2,3-Dichlorophenyl)-8-aza-5-azoniaspiro[4.5]decane Bromide chemical structure](/media/structures/SEDIOOIGAOGDMF-UHFFFAOYSA-M.svg)
8-(2,3-Dichlorophenyl)-8-aza-5-azoniaspiro[4.5]decane Bromide
- CAS
- 795313-24-5
- Formula
- C14H19BrCl2N2
- MW
- 366.1 g/mol
VQ-020825
FAQs — Aripiprazole impurities
Which Aripiprazole impurities do you supply?
We list 67 Aripiprazole-related reference materials, including process impurities, degradation products, nitrosamine impurities, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Aripiprazole impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Aripiprazole impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Aripiprazole impurity standards
We reply within one business day with price, pack options, lead time and documentation.